EAGLE PHARMACEUTICALS, INC. Annual Costs and Expenses in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2017 to 2022.
  • Eagle Pharmaceuticals, Inc. Costs and Expenses for the quarter ending June 30, 2023 was $54.3M, a 24.5% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending June 30, 2023 was $217M, a 0.99% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $236M, a 39.6% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $169M, a 9% increase from 2020.
  • Eagle Pharmaceuticals, Inc. annual Costs and Expenses for 2020 was $155M, a 11% decline from 2019.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $236M +$66.9M +39.6% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $169M +$13.9M +9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $155M -$19.2M -11% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $174M -$2.62M -1.48% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $177M +$14M +8.59% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $163M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.